The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Bio-Path Holdings, Inc(NASDAQ:BPTH) 
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA...
Website: http://www.biopathholdings.com
Founded: 2000
Full Time Employees: 9
Sector: Healthcare
Industry: Biotechnology
Bio-Path Days Payable Outstanding ttm (DPO)
Bio-Path Op Cashflow Per Share ttm
Bio-Path Free Cashflow Per Share ttm
Bio-Path Cash Per Share ttm
Bio-Path (GAAP) P/E ratio ttm
Bio-Path P/B ratio ttm
No extra charts and metrics for this ticker.